ArticleCancer gene therapy2009

Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.

M-S Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.